Results 21 to 30 of about 114,130 (205)
Hyaluronan-binding peptide for targeting peritoneal carcinomatosis
Peritoneal carcinomatosis results from dissemination of solid tumors in the peritoneal cavity, and is a common site of metastasis in patients with carcinomas of gastrointestinal or gynecological origin.
Hideki Ikemoto +11 more
doaj +2 more sources
Chronic Granulomatous Peritonitis From Recurrent Bilateral Ovarian Mature Cystic Teratomas Masquerade as Peritoneal Carcinomatosis. [PDF]
ABSTRACT Although rare, ruptured mature cystic teratoma (MCT) can cause chronic granulomatous peritonitis that mimics peritoneal carcinomatosis. In patients with a history of cystectomy for MCT, careful clinicoradiologic and histopathologic correlation is essential to avoid misdiagnosis and unnecessary aggressive treatment.
Sadeghian Z +6 more
europepmc +2 more sources
Refining OVCAR-3 xenograft models of peritoneal carcinomatosis in nu/nu mice: Comparative intraperitoneal implantation strategies and the role of basement membrane matrix. [PDF]
A refined murine model of advanced ovarian cancer was established by comparing localized preperitoneal implantation and intraperitoneal injection of OVCAR‐3Luc cells. While localized implantation showed limited tumor persistence, intraperitoneal delivery with BME produced sustained diffuse dissemination confirmed by BLI and histology, providing a ...
Perelló-Trias MT +5 more
europepmc +2 more sources
Peritoneal carcinomatosis [PDF]
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver and/or extraperitoneal metastases from gastrointestinal cancer.
Coccolini F +10 more
openaire +5 more sources
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of selected patients with peritoneal metastasis. A major cause of treatment-related morbidity after CRS/HIPEC is infection and sepsis. HIPEC
Lilian Roth +6 more
doaj +1 more source
New views on pathogenesis and diagnosis of peritoneal carcinomatosis
Peritoneal metastasis occurs in a number of heterogeneous tumors originating from the ovaries, stomach, intestines, pancreas, lungs, breast, and melanoma. Peritoneal carcinomatosis significantly reduces overall survival.
K. R. Ishmuratova, K. Sh. Gantsev
doaj +1 more source
Background Differential diagnosis between tuberculous peritonitis and peritoneal carcinomatosis remains challenging in clinical practice; thus, in-patients diagnosed with tuberculous peritonitis or peritoneal carcinomatosis were retrospectively enrolled,
Li Du +4 more
doaj +1 more source
Background The diagnosis of peritoneal carcinomatosis is challenging and can be difficult to detect with imaging, especially the detection of small-sized peritoneal lesions. The presence of peritoneal neoplastic spread alters tumour staging and is one of
Ahmed Abdelmonem Darweesh +3 more
doaj +1 more source
Diagnosis and treatment of peritoneal carcinomatosis – a comprehensive overview [PDF]
Peritoneal carcinomatosis, which is the most common malignant process of the peritoneal cavity, originates mostly from colorectal, gastric, and gynaecological malignancies.
Cieszanowski, Andrzej +5 more
core +1 more source
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications [PDF]
Simple Summary Peritoneal carcinomatosis mouse models as a platform to test, improve and/or predict the appropriate therapeutic interventions in patients are crucial to providing medical advances.
Di-Trani, C.A. (Claudia Augusta) +9 more
core +2 more sources

